ARKG vs MCHI
ARK Genomic Revolution ETF vs iShares MSCI China ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
MCHI—
iShares MSCI China ETF
Broad China equity exposure.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | MCHI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
MCHI top holdings
Holdings data unavailable for MCHI.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About MCHI
MCHI (iShares MSCI China ETF) is Broad China equity exposure.